Skip to main content

Table 2 Distribution and characteristics of FDG-avid supradiaphragmatic lymph nodes (sdLNs) in PET/CT

From: Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study

  Pre-operative PET/CT Treatment response evaluation PET/CT The 1st relapse PET/CT
The anatomical site of FDG-avid sdLNs Patients with FDG-avid sdLNs N (%) Mean short axis mm(±sd) Mean SUVmax (±sd) Patients with FDG-avid sdLNs N (%) Mean short axis mm(±sd) Mean SUVmax (±sd) Patients with FDG-avid sdLNs N (%) Mean short axis mm(±sd) Mean SUVmax (±sd)
Responders group (N = 29)
 Parasternal 17 (59) 5.6(±2.3) 2.7(±0.8) 2 (7) 2.2(±1.9) 1.7(±0.5) 7 (32) 5.7(±2.5) 4.0(±2.3)
 Subclavian 4 (14) 8.0(±2.3) 4.8(±1.9) 1 (3) 8.0(±3.2) 4.8 2 (9) 8.0(±3.6) 6.4(±4.3)
 Axillary 12 (41) 9.1(±4.4) 4.4(±3.9) 5 (17) 6.3(±3.2) 2.0(±0.8) 4 (18) 14.9(±7.0) 11.1(±9.4)
 Mediastinal 8 (28) 8.5(±2.5) 4.3(±1.8) 3 (10) 5.5(±2.9) 2.9(±0.3) 9 (41) 7.3(±1.4) 5.6(±3.5)
 Cardiophrenic 23 (79) 7.7(±4.4) 3.4(±2.1) 3 (10) 4.8(±1.6) 1.9(±0.05) 7 (32) 7.8(±6.2) 3.8(±3.4)
Total 29 (100) 7.6(±3.8) 3.6(±2.4) 10 (34) 5.5(±2.9) 2.3(±0.9) 13 (59) of 22 8.6(±5.5) 6.0(±5.6)
  Multiple sites 20 (69)    4 (14)    8 (36)   
  Single site 9 (31)    6 (20)    5 (23)   
Non-responders group (N = 12)
 Parasternal 11 (92) 4.9(±1.4) 2.9(±0.5) 5 (42) 8.5(±8.7) 1.8(±0.8)    
 Subclavian 2 (17) 14.3(±5.3) 6.2(±0.9) 1 (8) 5.0 3.8(±0.7)    
 Axillary 2 (17) 13.0(±5.1) 5.7(±3.1) 0    
 Mediastinal 6 (50) 12.4(±6.7) 5.2(±2.4) 3 (25) 8.2(±2.2) 3.3(±1.6)    
 Cardiophrenic 8 (67) 6.8(±1.6) 3.2(±1.2) 6 (50) 5.1(±1.4) 2.8(±1.2)    
Total 12 (100) 8.1(±5.1) 3.8(±2.0) 7 (58) 6.8(±4.9) 2.9(±1.4)    
  Multiple sites 11 (92)    3 (25)      
  Single site 1 (8)    4 (33)      
  1. Distribution and characteristics of FDG-avid supradiaphragmatic lymph nodes (sdLNs) in PET/CT in patients with advanced stage epithelial ovarian cancer at different time points of the disease